TScan Therapeutics, Inc.
USD0.98
+0.01 (+0.53%)
CEO
Gavin MacBeath
IPO Date
2021-07-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.97
Prev. Close
$0.98
Day Low
$0.96
Day High
$1.00
52W Low
$0.82
52W High
$2.57
Market Cap
$0.06B
Volume
0.08M
| -2.7 |
| 31 Dec 2023 | FY | 100.0% | -423.9% | -59.1% | -32.8% | 0.61 | 6.51 | -4.3 |
| 31 Dec 2022 | FY | 100.0% | -489.3% | -66.6% | -33.3% | 0.86 | 7.17 | -0.6 |
| 31 Dec 2021 | FY | 100.0% | -479.5% | -30.2% | -25.8% | 0.04 | 7.76 | -2.2 |
| 31 Dec 2020 | FY | -1796.5% | -2408.0% | 61.5% | -52.5% | -0.18 | 2.09 | -10.0 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -32.1% | -27.7% | 0.11 | 17.69 | -19.2 |
| -1.4 |
| 30 Sept 2025 | Q3 | 100.0% | -1422.1% | -24.8% | -13.6% | 0.66 | 6.44 | -1.7 |
| 30 Jun 2025 | Q2 | 100.0% | -1201.3% | -20.9% | -12.4% | 0.55 | 7.06 | -1.3 |
| 31 Mar 2025 | Q1 | 100.0% | -1571.9% | -16.2% | -10.3% | 0.46 | 8.55 | -1.3 |
| 31 Dec 2024 | Q4 | 100.0% | -5384.8% | -14.9% | -9.6% | 0.40 | 8.14 | -2.6 |
| 30 Sept 2024 | Q3 | 100.0% | -2849.1% | -13.0% | -8.6% | 0.39 | 9.56 | -4.9 |
| 30 Jun 2024 | Q2 | 100.0% | -5906.9% | -12.4% | -8.4% | 0.37 | 7.77 | -5.3 |
| 31 Mar 2024 | Q1 | 100.0% | -5325.4% | -24.5% | -12.5% | 0.75 | 5.23 | -6.3 |
| 31 Dec 2023 | Q4 | 82.2% | -272.0% | -13.0% | -7.2% | 0.61 | 6.51 | -7.0 |